Group 1: Marketing Strategies - The pharmaceutical business unit focuses on becoming the "first brand" in the field of injury and pain management, leading to significant growth in aerosol and plaster products [2] - A comprehensive marketing strategy integrates various scenarios such as sports and music, utilizing platforms like Douyin and Xiaohongshu for broad dissemination [3] - Online sales through O2O channels increased by over 20%, with a total of 48.45 million visitors and 3.54 million consumers generated, resulting in a GMV of 254 million yuan [3] Group 2: R&D Progress - The INR101 diagnostic nuclear medicine project has initiated Phase III clinical trials, with 32 research centers established and 60 subjects enrolled [4] - The INR102 therapeutic nuclear medicine project has received a clinical trial notification, with 12 patients enrolled in the Phase I trial [4] Group 3: Health Products Sales - The health products business unit maintains a strong offline presence while increasing investment in online channels, achieving the top market share for toothpaste in China during the first half of 2025 [6] - During the 2025 "618" shopping festival, Yangyuanqing ranked first in Tmall for domestic anti-hair loss shampoo brands [6] Group 4: Development Directions - The company aims for "internal" and "external" collaborative development to optimize its industrial portfolio, focusing on enhancing efficiency in the pharmaceutical, health, and distribution sectors [7] - "Internal" development emphasizes maximizing overall efficiency and high-quality growth across the entire value chain, while "external" development explores strategic mergers and collaborations to overcome growth bottlenecks [7]

投资者关系活动类别 □特定对象调研 □分析师会议 □媒体采访 □业绩说明会 □新闻发布会 □路演活动 □现场参观 □一对一沟通 ☑ 其他（电话会议） 参与单位名称及人员 姓名 国泰海通-张澄 人保资产-黄海培、吴瑞祥、章斌、武丹 时间 2026 年 1 月 22 日 地点 集团总部办公大楼 上市公司接待人员 董事会秘书-钱映辉 证券事务代表-李孟珏 投资者关系管理-张昱、杨可欣 投资者关系活动主要 内容介绍 了解公司生产经营情况 附件清单 会议记录 日期 2026 年 1 月 22 日星期四 编号：2-2601-02 云南白药集团股份有限公司 投资者调研会议记录表 1 / 1 ...

投资者关系活动类别 □特定对象调研 □分析师会议 □媒体采访 □业绩说明会 □新闻发布会 □路演活动 □现场参观 □一对一沟通 ☑ 其他（电话会议） 参与单位名称及人员 姓名 华西医药-程仲瑶 易方达-郭杰、余欣鑫、廖敏华、邓子晗、胡可冕 时间 2026 年 1 月 21 日 地点 集团总部办公大楼 上市公司接待人员 证券事务代表-李孟珏 投资者关系管理-张昱、杨可欣 投资者关系活动主要 内容介绍 了解公司生产经营情况 附件清单 会议记录 日期 2026 年 1 月 21 日星期三 1 / 1 投资者调研会议记录表 编号：1-2601-01 云南白药集团股份有限公司 ...

证券之星消息，1月23日中药板块较上一交易日上涨0.28%，*ST长药领涨。当日上证指数报收于 4136.16，上涨0.33%。深证成指报收于14439.66，上涨0.79%。中药板块个股涨跌见下表： 从资金流向上来看，当日中药板块主力资金净流出5.1亿元，游资资金净流出5225.91万元，散户资金净流 入5.62亿元。中药板块个股资金流向见下表： | 代码 | 名称 | 主力净流入(元) | 主力净占比 游资净流入(元) | | 游资净占比 散户净流入 (元) | | 散户净占比 | | --- | --- | --- | --- | --- | --- | --- | --- | | 000538 | 云南白药 | 2925.96万 | 3.91% | 124.39万 | 0.17% | -3050.36万 | -4.07% | | 002390 | 信邦制药 | 1707.83万 | 9.03% | -877.49万 | -4.64% | -830.34万 | -4.39% | | 600750 江中药业 | | 1112.58万 | 4.76% | 719.17万 | 3.08% | -- 1831. ...

Core Viewpoint - The report highlights the significant inflow of main capital into various stocks, with specific companies showing remarkable performance in terms of net capital inflow and stock price changes [1][2]. Group 1: Main Capital Inflow - A total of 88 stocks have experienced a net inflow of main capital for five consecutive days or more, indicating strong investor interest [1]. - Hangzhou Bank leads with 16 consecutive days of net inflow, followed by Yunnan Baiyao with 14 days [1]. - Midea Group has the highest total net inflow amounting to 1.582 billion yuan over seven days, while Hangzhou Bank follows closely with 1.489 billion yuan over 16 days [1]. Group 2: Performance Metrics - The stock with the highest net inflow ratio relative to trading volume is Fenglong Co., which has surged by 359.76% over the past 16 days [1]. - Other notable stocks include Guotai Junan Securities with a net inflow of 1.109 billion yuan over 11 days and China Ping An with 1.074 billion yuan over six days, although their stock prices have seen declines of 2.46% and 3.28% respectively [1]. - The report includes a detailed table of stocks with their respective net inflow amounts, inflow ratios, and cumulative price changes, providing a comprehensive overview of market trends [1][2].

Market Overview - The Shanghai Composite Index rose by 0.14% on January 22, with 22 out of the 28 sectors in the Shenwan classification experiencing gains, led by the construction materials and defense industries, which increased by 4.09% and 3.23% respectively [1] - The beauty and banking sectors saw the largest declines, with decreases of 0.76% and 0.43% respectively [1] Capital Flow Analysis - The main capital outflow from the two markets totaled 21.612 billion yuan, with 12 sectors experiencing net inflows [1] - The telecommunications sector had the highest net inflow, amounting to 8.019 billion yuan, and it rose by 2.83% [1] - The defense industry also saw significant inflow, with a net inflow of 5.713 billion yuan and a daily increase of 3.23% [1] - The electronics sector faced the largest net outflow, totaling 13.206 billion yuan, followed by the power equipment sector with an outflow of 7.206 billion yuan [1] Pharmaceutical and Biological Industry Performance - The pharmaceutical and biological sector declined by 0.42%, with a net capital outflow of 3.027 billion yuan [2] - Out of 478 stocks in this sector, 253 rose while 204 fell, with 2 stocks hitting the daily limit up [2] - The top three stocks with the highest net inflow were Sanbo Brain Science (1.42 billion yuan), Yunnan Baiyao (667.561 million yuan), and Innovation Medical (637.008 million yuan) [2] - The sector's outflow was led by Hengrui Medicine, which saw a net outflow of 372.7538 million yuan, followed by Xingqi Eye Medicine and Aidi Pharmaceutical with outflows of 208.3529 million yuan and 121.6946 million yuan respectively [3]

证券时报·数据宝统计，截至1月21日收盘，深沪北共101只个股连续5日或5日以上主力资金净流入。杭 州银行等连续15日主力资金净流入，排名第一；云南白药连续13日主力资金净流入，位列第二。从主力 资金净流入总规模来看，德明利主力资金净流入金额最大，连续6天累计净流入15.50亿元，杭州银行紧 随其后，15天累计净流入14.39亿元。从主力资金净流入占成交额的比例来看，锋龙股份占比排名居 首，该股近15日上涨317.94%。（数据宝） 连续5日或以上主力资金净流入个股排名 | 证券代 | 证券简 | 主力资金净流入 | 主力资金净流入金额 | 主力资金净流入比例 | 累计涨跌幅 | | --- | --- | --- | --- | --- | --- | | 码 | 称 | 天数 | （亿元） | （%） | （%） | | 001309 | 德明利 | 6 | 15.50 | 6.77 | 22.39 | | 600926 | 杭州银 行 | 15 | 14.39 | 9.88 | -0.65 | | 000333 | 美的集 团 | 6 | 11.55 | 6.11 | 2.07 | | 000776 | ...

| 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | | 成交额(元) | | --- | --- | --- | --- | --- | --- | --- | | 300391 | *ST长药 | 0.64 | 20.75% | | 51.97万 | 3217.33万 | | 600671 | 天目药业 | 22.29 | 8.47% | | 12.81万 | 2.82亿 | | 002082 | 万邦德 | 17.82 | 5.13% | | 19.68万 | 3.42 乙 | | 300147 | ST香雪 | 10.08 | 3.70% | 1 | 27.38万 | 2.79亿 | | 002107 | 沃华医药 | 7.41 | 2.92% | | 30.38万 | 2.27亿 | | 301331 | 恩威医药 | 29.70 | 2.20% | | 3.25万 | 9706.31万 | | 603139 | 康惠股份 | 21.70 | 1.40% | | 2.87万 | 6170.63万 | | 300519 | 新光药业 | 16.10 | 1.19% | | 2.51万 | ...

Group 1 - The Chinese medicine sector saw a rise of 0.54% on January 20, with *ST Changyao leading the gains [1] - The Shanghai Composite Index closed at 4113.65, down 0.01%, while the Shenzhen Component Index closed at 14155.63, down 0.97% [1] - Notable gainers in the Chinese medicine sector included *ST Changyao with a closing price of 0.53, up 20.45%, and ST Xiangxue with a closing price of 9.72, up 7.05% [1] Group 2 - The Chinese medicine sector experienced a net outflow of 23.25 million yuan from major funds, while retail investors saw a net inflow of 20.95 million yuan [2] - The top stocks by net inflow from retail investors included *ST Changyao and ST Xiangxue, with retail inflows of 2.20 million yuan and 4.16 million yuan respectively [3] - Major funds showed a significant net outflow in stocks like Zhongsheng Pharmaceutical and Yiling Pharmaceutical, with net outflows of 10.68 million yuan and 5.57 million yuan respectively [3]

Core Insights - The Shanghai Municipal Market Supervision Administration conducted a quality inspection of toothpaste products in 2025, with 30 batches tested and no non-compliance found [2]. Group 1: Inspection Results - The inspection was based on the JJF 1070-2023 standards for measuring the net content of packaged goods, focusing on net content labeling and actual net content [2]. - All tested toothpaste products met the relevant standards, indicating a high level of compliance in the market [2]. Group 2: Product Details - Various brands and types of toothpaste were included in the inspection, such as: - DARLIE's mineral toothpaste (120g) from Haolai Chemical [2] - Yunnan Baiyao's sensitive toothpaste (110g) from Yunnan Baiyao Group [2] - Colgate's 3D whitening toothpaste (90g) from Procter & Gamble [2] - The inspection covered products sold in multiple retail locations, including shopping malls and e-commerce platforms [2].